NDAINJECTIONINJECTABLE
Approved
Aug 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHIROCAINE (levobupivacaine hydrochloride) is a long-acting local anesthetic administered by injection for regional anesthesia and pain management. It is the S-enantiomer of bupivacaine, designed to provide prolonged sensory blockade with potentially improved cardiovascular safety. The drug is used across surgical and chronic pain settings where regional nerve blocks are clinically indicated.
LOE Approaching
As LOE approaches, commercial teams face declining revenue and potential workforce consolidation; focus shifts to defending market share against generic competitors.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CHIROCAINE offers limited career development given the product's mature lifecycle and approaching LOE. Roles are primarily defensive-focused on customer retention and pricing negotiations rather than growth initiatives.
Brand ManagerField Sales Representative
Worked on CHIROCAINE at Purdue Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.